What is the appropriate work-up for suspected myocarditis?

Work-up for Suspected Myocarditis

Begin with cardiac troponin (preferably high-sensitivity assay), ECG, and transthoracic echocardiography immediately, followed by cardiac MRI in all hemodynamically stable patients to establish a definitive diagnosis without requiring endomyocardial biopsy in most cases. 1

Initial Diagnostic Triad

The work-up starts with three essential tests that should be obtained promptly:

1. High-Sensitivity Cardiac Troponin

• Measure troponin levels above the 99th percentile upper reference limit to detect myocardial injury 2, 1
• Rising troponin levels mandate immediate cardiology consultation 1
• Troponin elevation is one of the three core diagnostic criteria for myocarditis 2

2. Electrocardiogram

• Look specifically for ST-segment elevation without reciprocal ST-segment depression (distinguishes from acute coronary syndrome) 2, 1
• Identify diffuse T-wave inversions 2
• Check for QRS complex prolongation 2
• Assess for AV blocks (first through third degree), bundle branch blocks, or ventricular arrhythmias 2
• ECG abnormalities trigger mandatory cardiology consultation 1

3. Transthoracic Echocardiography

• Evaluate left ventricular systolic function 1
• Identify regional wall motion abnormalities in a noncoronary distribution (key distinguishing feature) 2
• Rule out alternative diagnoses: valvular disease, congenital heart disease, other cardiomyopathies 2
• Assess for pericardial effusion or intracavitary thrombi 2
• Note that wall thickness may be increased due to edema in acute cases 2

Cardiac Magnetic Resonance Imaging (Definitive Diagnosis)

CMR should be performed in all hemodynamically stable patients with suspected myocarditis, as it provides definitive diagnosis without endomyocardial biopsy in most cases. 1

CMR Findings Diagnostic of Myocarditis

• Nonischemic late gadolinium enhancement (LGE) pattern 2
• Prolonged native T1 relaxation times (indicates fibrosis or inflammation) 2
• Prolonged T2 relaxation times (indicates inflammation or edema) 2
• CMR has largely replaced the need for endomyocardial biopsy except in specific circumstances 1, 3

Diagnostic Certainty Categories

The diagnosis is stratified into three levels based on available evidence 2:

Possible Myocarditis

• Cardiac symptoms (chest pain, dyspnea, palpitations, syncope) present 2
• Elevated cardiac troponin 2
• Abnormal ECG and/or echocardiographic findings 2
• But CMR or biopsy either shows no acute myocarditis or was not performed 2
• Ideally exclude coronary artery disease in men >50 years and women >55 years 2

Probable Myocarditis

• All features of possible myocarditis present 2
• Follow-up CMR and/or biopsy within 6 months demonstrates abnormalities consistent with previous myocarditis 2

Definite Myocarditis

• All features of possible myocarditis present 2
• CMR and/or biopsy performed acutely demonstrates findings consistent with active myocarditis 2

When to Perform Endomyocardial Biopsy

Biopsy is reserved for specific clinical scenarios and is not routinely required 1:

• Fulminant myocarditis with hemodynamic compromise not responding to standard therapy 4, 5
• Suspected giant cell myocarditis or eosinophilic myocarditis (requires histologic confirmation for immunosuppression decisions) 4, 6
• Suspected cardiac sarcoidosis 6
• When etiology-specific treatment is being considered (e.g., immunosuppression for virus-negative inflammatory cardiomyopathy) 6
• Nonresponders to standard therapy even at later stages 5

Additional Laboratory Testing

While not diagnostic alone, these tests support the clinical picture 2:

• Serum inflammatory markers (C-reactive protein, ESR) - though sensitivity is limited 2
• Natriuretic peptides (BNP/NT-proBNP) for heart failure assessment 2
• Viral serology is not routinely recommended due to poor specificity 2

Coronary Artery Disease Exclusion

In patients presenting with chest pain and troponin elevation, acute coronary syndrome must be excluded, particularly in men >50 years and women >55 years. 2

• This typically requires coronary angiography or CT coronary angiography 2, 4
• The absence of flow-limiting epicardial coronary disease is part of the diagnostic criteria 2

Risk Stratification at Presentation

Severity assessment guides hospital placement and intensity of monitoring 1:

Mild-to-Moderate Severity

• Admit to advanced heart failure center 1
• Hemodynamically stable 1
• No sustained ventricular arrhythmias 1

Fulminant Presentation (High-Risk Features)

• Hemodynamic compromise or cardiogenic shock 1
• Sustained ventricular arrhythmias 1
• High-grade atrioventricular block 1
• Requires immediate transfer to facility with mechanical circulatory support capability (e.g., VA-ECMO) 1

Common Pitfalls to Avoid

• Do not rely on symptom intensity to gauge severity - symptoms correlate poorly with LVEF, troponin levels, natriuretic peptides, and C-reactive protein 2
• Do not assume viral serology is diagnostic - routine viral testing lacks specificity 2
• Do not delay CMR in stable patients - it is the preferred definitive diagnostic test and avoids unnecessary biopsies 1, 3
• Do not miss the noncoronary distribution of wall motion abnormalities - this distinguishes myocarditis from ischemic injury 2
• Do not forget to exclude coronary disease in older patients - age-appropriate coronary evaluation is essential 2

Follow-Up Testing

Perform repeat evaluation at 3-6 months after initial presentation 1:

• Repeat ECG 1
• Repeat echocardiogram 1
• Ambulatory rhythm monitoring 1
• Follow-up CMR, especially in patients with ongoing symptoms or significant initial myocardial involvement 1
• Approximately 41% show resolution of CMR abnormalities by median 8 weeks, though clinical recovery often takes longer 1